StemRIM (TSE:4599) ROCE %: -28.13% (As of Jan. 2026)


TSE:4599 StemRIM Inc TSE:4599
34 GF Score
Price 円313.00
! 2 Warning Signs
View Full Analysis

What is StemRIM ROCE %?

StemRIM TSE:4599 +0.64% 34 ROCE % is -28.13% as of Jan. 2026. GuruFocus rates TSE:4599 with a GF Score™ of 34/100. The stock has 2 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. StemRIM's annualized ROCE % for the quarter that ended in Jan. 2026 was -28.13%.

StemRIM  (TSE:4599) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

StemRIM ROCE % Related Terms

StemRIM ROCE % Historical Data

* Premium members only.

The historical data trend for StemRIM's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

StemRIM ROCE % Chart

StemRIM Annual Data
Trend Jul17 Jul18 Jul19 Jul20 Jul21 Jul22 Jul23 Jul24 Jul25
ROCE %
Get a 7-Day Free Trial Premium Member Only -5.30 -19.13 1.70 -20.70 -23.45

StemRIM Semi-Annual Data
Jul17 Jul18 Jul19 Jan20 Jul20 Jan21 Jul21 Jan22 Jul22 Jan23 Jul23 Jan24 Jul24 Jan25 Jul25 Jan26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -19.66 -21.43 -24.66 -21.94 -28.13
TSE:4599
34GF Score
StemRIM Inc TSE:4599
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

StemRIM ROCE % Calculation

StemRIM's annualized ROCE % for the fiscal year that ended in Jul. 2025 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Jul. 2025 )  (A: Jul. 2024 )(A: Jul. 2025 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Jul. 2025 )  (A: Jul. 2024 )(A: Jul. 2025 )
=-1927.784/( ( (9080.415 - 67.527) + (7518.659 - 87.884) )/ 2 )
=-1927.784/( (9012.888+7430.775)/ 2 )
=-1927.784/8221.8315
=-23.45 %

StemRIM's ROCE % of for the quarter that ended in Jan. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Jan. 2026 )  (Q: Jul. 2025 )(Q: Jan. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Jan. 2026 )  (Q: Jul. 2025 )(Q: Jan. 2026 )
=-1985.834/( ( (7518.659 - 87.884) + (6812.736 - 123.667) )/ 2 )
=-1985.834/( ( 7430.775 + 6689.069 )/ 2 )
=-1985.834/7059.922
=-28.13 %

(1) Note: The EBIT data used here is two times the semi-annual (Jan. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of -28.13% mean?
StemRIM (TSE:4599) has a ROCE % of -28.13% as of Jan. 2026.
Is StemRIM's ROCE % too high?
StemRIM's current ROCE % is -28.13%. Overall, StemRIM has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does StemRIM's ROCE % compare to VRTX and REGN?
StemRIM's ROCE % of -28.13% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Biotechnology company?
A good ROCE % depends on the Biotechnology industry context. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. StemRIM's current ROCE % is -28.13%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is StemRIM stock overvalued right now?
StemRIM (TSE:4599) has a current ROCE % of -28.13%. The current ROCE % is -28.13%. StemRIM's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For StemRIM (TSE:4599), the current ROCE % is -28.13% as of Jan. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

StemRIM Business Description

Address 7-15 Ayato Bio Incubator 3rd floor, Ayato Asagi 7-chome, Prefecture Ibaraki City, Osaka, JPN, 567-0085
StemRIM Inc is a biotechnology company engaged in developing regeneration-guided medicines. The business activity of the group includes research, development, manufacture, and sales of pharmaceuticals and medical devices and products such as gene therapy that activate stem cells existing in the body and induce regeneration of damaged tissue.
34GF Score

Get the complete analysis for TSE:4599

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円313.00
Price